Expression of CD74 in high grade gliomas: a potential role in temozolomide resistance

By Kitange Gaspar   Carlson Brett   Schroeder Mark   Decker Paul   Morlan Bruce   Wu Wenting   Ballman Karla   Giannini Caterina   Sarkaria Jann  

Journal of Neuro-Oncology, Vol. 100, Iss. 2, 2010-11 ,pp. : 177-186

Springer Publishing Company

Access to resources Recommend Favorite

Interferonβ and temozolomide combination therapy for temozolomide monotherapyrefractory malignant gliomas

By            

Molecular and Clinical Oncology, Vol. 3, Iss. 4, 2015-01 ,pp. : 909-913

Science Publishers

Access to resources Recommend Favorite

Evaluation of p53 and Bcl-2 Expression as Prognostic Markers in Invasive Cervical Carcinoma Stage IIb/III Patients Treated by Radiotherapy

By Jain D.   Srinivasan R.   Patel F.D.   Kumari Gupta S.  

Gynecologic Oncology, Vol. 88, Iss. 1, 2003-01 ,pp. : 22-28

Academic Press

Access to resources Recommend Favorite

Prognostic role of p53 codon 72 polymorphism in gastric cancer patients treated with fluorouracil-based adjuvant chemotherapy

By Huang Zhao-Hui   Hua Dong   Li Li-Hua   Zhu Jing-De  

Journal of Cancer Research and Clinical Oncology, Vol. 134, Iss. 10, 2008-10 ,pp. : 1129-1134

Springer Publishing Company

Access to resources Recommend Favorite

Steroid requirements during radiotherapy for malignant gliomas

By Marantidou Athina   Levy Christine   Duquesne Alyette   Ursu Renata   Bailon Olivier   Coman Irene   Belin Catherine   Carpentier Antoine  

Journal of Neuro-Oncology, Vol. 100, Iss. 1, 2010-10 ,pp. : 89-94

Springer Publishing Company

Access to resources Recommend Favorite